Literature DB >> 1322243

Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.

A Laatikainen1, L Schultz-Suhonen, R Mäntyjärvi.   

Abstract

The effect of interferon gamma (IFN gamma) on the immunogenicity and immunosensitivity of mouse cell lines transformed by bovine papillomavirus type 1 (BPV1) DNA was examined in a syngeneic mouse model. The overnight incubation of BPV1-transformed cell lines with 100 IU/ml IFN gamma did not affect their ability to induce the generation of cytotoxic effector cells but it clearly increased their sensitivity to lysis by interleukin-2-induced lymphokine-activated killer (LAK) cells and by non-specific LAK-type effector cells induced by BPV-1-transformed cell lines. The treatment of two allogeneic lymphoid tumour cell lines, P815X2 and YAC-1, with IFN gamma either decreased or had no effect on their sensitivity to LAK-cell-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322243     DOI: 10.1007/bf01756189

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

Review 1.  Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Review article.

Authors:  K J Syrjänen
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

2.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

3.  Inverse relationship in H-2-associated lysis between NK cells and rIL-2-activated killer cells: evidence from in vitro killing and metastatic experiments.

Authors:  A Toshitani; K Taniguchi; Y Kawano; K Nomoto
Journal:  Cell Immunol       Date:  1987-08       Impact factor: 4.868

4.  Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.

Authors:  H Naganuma; R Kiessling; M Patarroyo; M Hansson; R Handgretinger; A Grönberg
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

5.  Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon.

Authors:  S S Bao; N J King; C G dos Remedios
Journal:  Immunol Cell Biol       Date:  1990-08       Impact factor: 5.126

6.  Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.

Authors:  A Laatikainen; H Karjalainen; H Sarkkinen; K Syrjänen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.

Authors:  A Laatikainen; H Karjalainen; H Jägerroos; H Sarkkinen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  Decreased susceptibility of lined human gliosarcoma cells to lymphokine-activated killer cell cytolysis by gamma-interferon treatment.

Authors:  S Miyatake; H Kikuchi; Y Oda; T Nishioka; J Takahashi; S Kondoh; M Matsumoto; T Yamasaki; K Iwasaki; T Aoki
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

9.  Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.

Authors:  R Mäntyjärvi; H Sarkkinen; S Parkkinen; A Laatikainen; A Ryhänen; K Syrjänen
Journal:  Intervirology       Date:  1988       Impact factor: 1.763

10.  Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras.

Authors:  W J Bateman; R Fiera; N Matthews; A G Morris
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  1 in total

1.  Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.

Authors:  C Fady; A Gardner; J F Gera; A Lichtenstein
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.